Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function

Evidence suggests that increased microRNA-155 (miR-155) expression in immune cells enhances antitumor immune responses. However, given the reported association of miR-155 with tumorigenesis in various cancers, a debate is provoked on whether miR-155 is oncogenic or tumor suppressive. We aimed to int...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junfeng, Wang, Quanyi, Guan, Yinan, Sun, Yulu, Wang, Xiaozhi, Lively, Kaylie, Wang, Yuzhen, Luo, Ming, Kim, Julian A., Murphy, E. Angela, Yao, Yongzhong, Cai, Guoshuai, Fan, Daping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525116/
https://www.ncbi.nlm.nih.gov/pubmed/35925680
http://dx.doi.org/10.1172/JCI157248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525116/
https://www.ncbi.nlm.nih.gov/pubmed/35925680
http://dx.doi.org/10.1172/JCI157248

Ejemplares similares